These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9035067)

  • 1. Pharmacokinetics and toxicokinetics of bio-pharmaceuticals: technical problems.
    Kawai M
    J Toxicol Sci; 1996 Dec; 21(5):535-7. PubMed ID: 9035067
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug metabolites in safety testing.
    Hastings KL; El-Hage J; Jacobs A; Leighton J; Morse D; Osterberg RE
    Toxicol Appl Pharmacol; 2003 Jul; 190(1):91-2;author reply 93-4. PubMed ID: 12831788
    [No Abstract]   [Full Text] [Related]  

  • 3. ICH discussion on pharmacokinetics and toxicokinetics and contributors.
    Ohno Y
    Drug Metab Pharmacokinet; 2013; 28(5):379-82. PubMed ID: 24162438
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs in control samples in nonclinical safety studies: a reconsideration.
    Zimmer D
    Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047
    [No Abstract]   [Full Text] [Related]  

  • 5. Current drug metabolism.
    Kerns EH
    Curr Drug Metab; 2008 Nov; 9(9):845-6. PubMed ID: 18991579
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences between pharmacokinetics and toxicokinetics.
    Welling PG
    Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdosing for reduction of the time and resources for drug development.
    Sudo K
    Drug Metab Pharmacokinet; 2007 Oct; 22(5):327. PubMed ID: 17965515
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of modeling and simulation: myth or fact?
    Allerheiligen SR
    Clin Pharmacol Ther; 2014 Oct; 96(4):413-5. PubMed ID: 25236663
    [No Abstract]   [Full Text] [Related]  

  • 11. Requirements for a lead compound to become a clinical candidate.
    Hefti FF
    BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S7. PubMed ID: 19091004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internet resources for proteins associated with drug therapeutic effects, adverse reactions and ADME.
    Ji ZL; Sun LZ; Chen X; Zheng CJ; Yao LX; Han LY; Cao ZW; Wang JF; Yeo WK; Cai CZ; Chen YZ
    Drug Discov Today; 2003 Jun; 8(12):526-9. PubMed ID: 12821296
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial. Role of Drug Transport and Pharmacokinetics in Drug Efficacy and Safety Part 1.
    Liu C; He X
    Curr Drug Metab; 2015; 16(9):730-1. PubMed ID: 26630904
    [No Abstract]   [Full Text] [Related]  

  • 14. In silico methods to predict drug toxicity.
    Roncaglioni A; Toropov AA; Toropova AP; Benfenati E
    Curr Opin Pharmacol; 2013 Oct; 13(5):802-6. PubMed ID: 23797035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-clinical safety studies for biotechnologically-derived pharmaceuticals: conclusions from an international workshop.
    Griffiths SA; Lumley CE
    Hum Exp Toxicol; 1998 Feb; 17(2):63-83. PubMed ID: 9506257
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial. Bioactivation of drugs: enzymes, reactive metabolites and adverse reactions.
    Orhan H
    Curr Med Chem; 2015; 22(4):406-7. PubMed ID: 25515506
    [No Abstract]   [Full Text] [Related]  

  • 17. The long, hard road: drug metabolism in the lifetime of the DMDG.
    Smith DA
    Xenobiotica; 2001; 31(8-9):459-67. PubMed ID: 11569522
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolite identification and profiling in drug design: current practice and future directions.
    Zhang Z; Zhu M; Tang W
    Curr Pharm Des; 2009; 15(19):2220-35. PubMed ID: 19601824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of drug metabolites.
    Izumi T
    Drug Metab Pharmacokinet; 2011; 26(2):121-2. PubMed ID: 21532211
    [No Abstract]   [Full Text] [Related]  

  • 20. A decade of drug metabolite safety testing: industry and regulatory shared learning.
    Luffer-Atlas D; Atrakchi A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):897-900. PubMed ID: 28797172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.